Navigation Links
NARSAD - the World's Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th
Date:10/15/2007

Prize winners have significantly contributed to the knowledge and treatment

of schizophrenia, depression, anxiety and childhood mental disorders

NEW YORK, Oct. 15 /PRNewswire/ -- Five of the most prestigious awards in psychiatric research will be presented to scientists of great achievement by NARSAD, the world's leading charity dedicated to mental health research, at an awards dinner here this Friday at the Waldorf-Astoria Hotel.

Because of NARSAD's distinctive history of contributing to the support and public understanding of neuropsychiatric research, the organization is able each year to recognize those scientists whose career achievements are especially noteworthy. The selections are made by NARSAD's distinguished 103- member Scientific Council, a volunteer body of leading experts in neuroscience and psychiatric research.

This year's prize recipients have made exceptional contributions to the understanding and treatment of schizophrenia, depression, obsessive compulsive disorder (OCD) and other anxiety disorders, Tourette's syndrome, and cognitive dysfunctions that underlie many mental illnesses.

The prizes and their recipients are:

* Lieber Prize for Schizophrenia Research: Eve C. Johnstone, M.D.,

University of Edinburgh, has devoted 30 years to conducting brain-

imaging and other anatomical studies of schizophrenia that have

provided a substantial body of evidence on the abnormalities of brain

structure in people with the disease and on the mechanism of

antipsychotic treatments. She initiated the most replicated finding in

the literature on psychosis -- enlargement of the lateral ventricles in

the brain.

* Falcone Prize for Mood Disorders Research: Helen S. Mayberg, M.D.,

Emory University, has led brain-imaging studies over the past 20 years

to examine neural mechanisms implicated in the onset of depression and

to study p
'/>"/>

SOURCE NARSAD
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Benefits Of The Worlds Most Widely Used Beverage
2. Worlds Largest Cord Blood Bank to be started in India
3. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
4. Worlds first mobile light surgery
5. Spanish Doctors Performs Worlds First Hand Transplantation Successfully
6. Worlds Heaviest Man Loses Weight Thanks to Monitored Dieting
7. Abu Dhabi to Have Worlds First Zero-carbon City
8. Eddie Murphy Voted Worlds Biggest Love-Rat
9. Is Diabetes the Leading Cause of Kidney Failure in India
10. Misleading anti-malarial drug
11. Misleading Advertisements for Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Minn. -- Mayo Clinic researchers have used next generation ... aggressive prostate cancer tumors have similar genetic origins, which ... online today in the journal Cancer Research . ... alterations using next generation sequencing in adjacent Gleason patterns ... with changes in pathology," says ,John Cheville, M.D., Mayo ...
(Date:5/23/2013)... Transvaginal mesh lawsuit claims ... move forward in a federal multidistrict litigation underway in ... Liebhard LLP reports. In an Order issued on ... Bard to seal emails that included supplier information the ... proprietary information about its suppliers. The emails were filed ...
(Date:5/23/2013)... May 23, 2013 The vast majority ... deal of control over their level of physical activity, ... far fewer are actually taking that control. Those ... Council (IFIC) Foundation’s 2013 Food & Health Survey. , ... it’s possible to have “a great deal of control” ...
(Date:5/23/2013)... Fort Myers, FL (PRWEB) May 23, 2013 ... daring prediction in the midst of growing numbers of H7N9 ... of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in ... of May 13th no new cases have been reported. ... of the flu is as predictable as flowers budding in ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Cheap Concert Tickets ... the Summer of 2013 at stadiums throughout North America. ... board on Paul McCartney concert tickets to help McCartney fans ... of Cheap Concert Tickets, states that she is also offering ... concert tickets. Being a baby boomer, she is also ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2
... MD, Launch Daily Syndicated ... Newspaper Column, SAN DIEGO ... to keep the health momentum going than the YOU Docs,Michael Roizen, MD, ... Oprah Winfrey Show. King Features Syndicate and,RealAge.com announce the launch of a ...
... TORRANCE, Calif., May 5 A landmark study shows,dangerous ... breast milk,but can be significantly reduced by Chlorella pyrenoidosa., ... Food, analyzed dioxin,levels in breast milk from 35 pregnant ... pyrenoidosa supplements. The study showed toxic levels,were significantly lower ...
... Ill., May 5 With spring in the ... all the essentials that warm weather,brings -- flip ... The available options in sunscreen protection have become ... application,or enhanced protection from ultraviolet (UV) light. Fortunately,dermatologists ...
... Marjorie Greenfield, M.D.,obstetrician- gynecologist at University ... week with The Working Woman,s,Pregnancy Book., ... physical and,emotional changes of each trimester, to ... this up-to-date guide discusses in a warm ...
... by which the epidermal growth factor receptor (EGFR), a ... kinase-independent mechanism. The research, published by Cell Press in ... a rationale for the less than impressive results of ... activity and suggests new directions for potential therapeutic strategies. ...
... Recovering sex addict Michael Leahy tells his personal story ... CHICAGO, May 5 It is accessible from,anywhere. ... of work, and,even our homes. An estimated 40 million ... the 2006 revenues of sex and,the porn industry in ...
Cached Medicine News:Health News:Need a Daily Dose of Good Health Advice to Keep You Going? 2Health News:Need a Daily Dose of Good Health Advice to Keep You Going? 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 2Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 4Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 5Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 6Health News:University Hospitals Physician Authors Working Woman's Pregnancy Book 2Health News:EGFR protects cancer cells from starvation via a kinase-independent mechanism 2Health News:Porn Nation Uncovers the Sexualization of America 2
(Date:5/23/2013)... 23, 2013  Inhibikase Therapeutics, Inc., an emerging ... it will present new results on its antiviral ... sponsored by the PML Consortium (composed of Pfizer, ... (JCV) is the causative agent of Progressive Multifocal ... in an extended release formulation, can clear JC ...
(Date:5/23/2013)... , May 23, 2013  Echo Pharma Acquisition Limited ... waive down the Acceptance Threshold from 90 percent to ... Elan Share in accordance with the terms of the ... summarized below. Under the terms of the ... (NYSE: ELN ) for $12.50 per share ...
(Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
... director of the Huntington Hospital Cancer Center, performed the first ... week. In a typical resection there are three ports ... across the belly in an open procedure. , ... offer shorter lengths of stay, less pain and quicker return ...
... from a pivotal trial suggests that ofatumumab has activity ... , , , ... Genmab A/S (OMX: GEN) announced today positive results from ... in the treatment of refractory chronic lymphocytic leukemia (CLL). ...
Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9
... of the first steps any hospital or ... the most powerful, most effective tools available ... CliniComps world-class clinician documentation and electronic medical ... systems achieve this goal. In fact, its ...
... Care, the world-class clinician documentation and electronic ... focus on the specific needs of intensive ... Its broad, deep clinical functionality has secured ... EMR solution in critical care, and its ...
... very popular only a few are really ... Explore why MediTalk is rapidly becoming the ... administrators. An EMR designed by physicians from ... patients quickly and efficiently while improving workflow ...
MediNotes e is an EMR design which utilizes a "tab concept for navigation. MediNotes e can display multiple patients, encounter notes, workflow items, patient flow, messages, alerts, and more, all in...
Medicine Products: